Jim C. Mullen

Chairman, President & Chief Executive Officer at Editas Medicine, Inc.

Jim C. Mullen

Jim C. Mullen

Chairman, President & Chief Executive Officer at Editas Medicine, Inc.

Overview
Career Highlights

Biogen Idec New Ventures, Inc.
Editas Medicine, Inc.
Patheon NV

RelSci Relationships

2977

Number of Boards

16

Birthday

1959

Age

62

Contact Data
Trying to get in touch with Jim C. Mullen? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Jim C. Mullen likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former President, Research & Development at Biogen, Inc.

Relationship likelihood: Strong

Chief Executive Officer at Biogen, Inc.

Relationship likelihood: Strong

Founder at Vicarius Pharma AG

Relationship likelihood: Strong

Former President & Chief Executive Officer at Boston Scientific Corporation

Relationship likelihood: Strong

Scientific Founder at Editas Medicine, Inc.

Relationship likelihood: Strong

Scientific Co-Founder at Inari Agriculture, Inc.

Relationship likelihood: Strong

Founder at J Hopfield Consulting

Relationship likelihood: Strong

Scientific Founder at Editas Medicine, Inc.

Relationship likelihood: Strong

Scientific Founder at Editas Medicine, Inc.

Relationship likelihood: Strong

Chief Executive Officer at Alnylam Pharmaceuticals, Inc.

Relationship likelihood: Strong

Paths to Jim C. Mullen
Potential Connections via
Relationship Science
You
Jim C. Mullen
Chairman, President & Chief Executive Officer at Editas Medicine, Inc.
Education
MBA
Class of 1984

Villanova School of Business is a school in Villanova.

Bachelor of Science in Chemical Engineering
Class of 1980

Rensselaer Polytechnic Institute, or RPI, is a private research university located in Troy, New York, with two additional campuses in Hartford and Groton, Connecticut. It was founded in 1824 by Stephen van Rensselaer and Amos Eaton for the "application of science to the common purposes of life" and is the oldest technological university in the English-speaking world.

Career History
Chairman, President & Chief Executive Officer
2018 - Current

Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA.

Chief Executive Officer & Executive Director
2011 - 2017

Patheon NV engages in the provision of pharmaceutical development and manufacturing services. It focuses on drug development, clinical trial logistics, and commercial manufacturing. The company was founded on December 24, 2013 and is headquartered in Amsterdam, the Netherlands.

Chief Executive Officer
2011 - Prior

Patheon, Inc. provides drug development and manufacturing services to global pharmaceutical, biotechnology and specialty pharmaceutical companies. It operates through two segments: Commercial Manufacturing Outsourcing and Pharmaceutical Development Services. The Commercial Manufacturing Outsourcing segment manufactures prescription products in sterile dosage forms as well as solid and liquid conventional dosage forms. The Pharmaceutical Development Services segment provides a broad range of development services, including solid and sterile dosage forms. The company operates through four market segments: Biologics, Emerging Pharma, Generics and Large Pharma. Patheon was founded in 1974 and is headquartered in Mississauga, Canada.

Boards & Committees
Non-Executive Chairman
Current

Percivia LLC engages in the research and development of vaccine and recombinant protein products. The company was founded in 2006 and is headquartered in Cambridge, MA.

Independent Director
2004 - Prior

As a global technology leader, PerkinElmer is taking action to harness the power of insights and transform them into knowledge to deliver innovative, differentiated solutions for our customers. From critical therapeutic and disease research and prenatal screening, to environmental testing and industrial monitoring, we are actively engaged in improving health and advancing quality and longevity of life all around the world. From multi-vendor laboratory services, software and informatics, to clinical lab testing and unparalleled customer care, we have the people, tools and resources to help customers solve their business and scientific goals. Our core competencies, coupled with our commitment to excellence, provide a strong foundation for delivering optimal service and support. By encouraging exploration, ingenuity and integrity, together with teamwork and employee development, at PerkinElmer we live our mission, every day

Member, Board of Directors
Current

The Biomedical Science Careers Program (BSCP) was founded in 1991 by Joan Y. Reede, M.D., M.P.H., M.S., M.B.A, with the aim of increasing the representation of underrepresented minority and disadvantaged individuals in all facets of science and medicine while helping health care institutions, biopharma/biotechnology firms, educational institutions, professional organizations and private industry members meet their need for a diverse workforce. BSCP was incorporated as a not-for-profit organization in 1994. The founding sponsors of BSCP are the Harvard Medical School Minority Faculty Development Program, the New England Board of Higher Education and the Massachusetts Medical Society.

Chairman, Board of Directors
Prior - 2007

Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.

Political Donations
$500
2010

Governor at Massachusetts Office of the Governor, Charles Baker

$500
2006

President at Milken Institute - Center for Advancing the American Dream

Transactions
Details Hidden

Patheon, Inc. purchases Banner Pharmacaps, Inc. from Noordbrabantse Christelijke Boerenbond, Rooms-Katholieke

Investments
Details Hidden

Vicarius Pharma bridges the gap between traditional go-it-alone and out-licensing strategies by providing a low risk shared-value approach.they offer research-driven pharmaceutical, biotech and medical devices companies a platform of excellence from which we build a dedicated European commercial organization.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Jim C. Mullen. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Jim C. Mullen's profile does not indicate a business or promotional relationship of any kind between RelSci and Jim C. Mullen.